The response of the fibrinolytic system to inflammatory mediators in empyema and complicated parapneumonic pleural effusions is still uncertain. We prospectively analysed 100 patients with pleural effusion: 25 with empyema or complicated parapneumonic effusion, 22 with tuberculous effusion, 28 with malignant effusion and 25 with transudate effusion. Inflammatory mediators, tumour necrosis factor-α (TNF-α), interleukin-8 (IL-8) and polymorphonuclear elastase, were measured in serum and pleural fluid. Fibrinolytic system parameters, plasminogen, tissue-type plasminogen activator (t-PA) and urokinase PA, PA inhibitor type 1 (PAI 1) and PAI type 2 concentrations and PAI 1 activity, were quantified in plasma and pleural fluid. The Wilcoxon signedrank test was used to compare plasma and pleural values and to compare pleural values according to the aetiology of the effusion. The Pearson correlation coefficient was used to assess the relationship between fibrinolytic and inflammatory markers in pleural fluid. Significant differences were found between pleural and plasma fibrinolytic system levels. Pleural fluid exudates had higher fibrinolytic levels than transudates. Among exudates, tuberculous, empyema and complicated parapneumonic effusions demonstrated higher pleural PAI levels than malignant effusions, whereas t-PA was lowest in empyema and complicated parapneumonic pleural effusions. PAI concentrations correlated with TNF-α, IL-8 and polymorphonuclear elastase when all exudative effusions were analysed, but the association was not maintained in empyema and complicated parapneumonic effusions. A negative association found between t-PA and both IL-8 and polymorphonuclear elastase in exudative effusions was strongest in empyema and complicated parapneumonic effusions. Blockage of fibrin clearance in empyema and complicated parapneumonic effusions was associated with both enhanced levels of PAIs and decreased levels of t-PA.
INTRODUCTION
Pleural effusion is a common clinical condition that can accompany a large variety of diseases [1, 2] . When bacterial infection occurs, increased vascular permeability and local release of inflammatory mediators may result in a pleural cavity reaction consisting of fluid accumulation with a high number of inflammatory cells [3] . Tumour necrosis factor-α (TNF-α) and interleukin (IL)-8 are powerful mediators with a key role in the inflammation involved in the pathogenesis of infectious pleural effusions [4] [5] [6] [7] [8] [9] . TNF-α is a 17 kDa proinflammatory cytokine released by mesothelial cells that induces a local inflammatory response by liberation of IL-8, IL-1 and IL-6. Empyema and complicated parapneumonic effusions have a high level of pleural TNF-α, but the highest concentration is found in tuberculous effusions [10] . IL-8 is an 8.3 kDa proinflammatory cytokine that acts as a potent chemoattractant for neutrophils and activates neutrophil degranulation with release of polymorphonuclear elastase [4, 5, 9, 11] . Neutrophil activity against bacterial infection depends on oxygen-dependent and oxygen-independent mechanisms. The system of neutral proteases is one of the most important among the oxygen-independent mechanisms, particularly polymorphonuclear elastase, which brings about non-specific proteolysis [11] .
The essential role of inflammatory mediators in the activation of the coagulation and fibrinolysis systems has been extensively assessed in experimental studies and in specific pathologies, such as sepsis, and its importance in the development of complications has been demonstrated [12] [13] [14] [15] [16] . The correlation between inflammatory markers and the fibrinolytic system has also been assessed in these studies [12] [13] [14] [15] [16] , but, to our knowledge, there are few previous reports addressing this association in pleural effusion [17, 18] .
In empyema and complicated parapneumonic pleural effusions, fibrin deposition can occur within the pleural space, and this participates in the formation of loculations and the emergence of complications [19] . The fibrinolytic system, which is responsible for fibrin balance, is regulated by a precise interplay between activators and inhibitors [20, 21] . The plasminogen activators (PAs), tissue-type PA (t-PA) and urokinase PA (u-PA) modulate the activation of the inactive plasminogen precursor, which results in fibrin digestion and the production of soluble degradation products (D-dimer). The PA inhibitors type 1 and type 2 (PAI 1 and PAI 2 respectively) down-regulate the PAs. Inhibition of fibrinolysis due to high concentrations of PAIs is associated with inflammatory or infectious effusions, whereas intrapleural hyperfibrinolysis, due mainly to excessive concentrations of t-PA and u-PA, is associated with malignant effusions [21] .
On the basis that increased levels of proinflammatory mediators and inhibition of fibrin degradation have been associated with the inflammatory response in the pleural space [4, 6, 20, 21] , we designed a prospective study to evaluate the relationships between these factors in empyema and complicated parapneumonic pleural effusions.
This work was presented at the American Thoracic Society International Conference held in Toronto, Canada, in May 2000, and subsequently published in abstract form [22] .
METHODS

Patients
From June 1997 to December 1998, 100 consecutive hospitalized patients with pleural effusion were studied at the Vall d'Hebron University Hospital in Barcelona. The study was approved by the Local Ethics Committee (Comissió d'Ética i Assaigs Clínics dels Hospitals Vall d'Hebrón).
The pleural effusions included 25 empyema or complicated parapneumonic effusion, 22 tuberculous effusion, 28 malignant effusion and 25 transudative effusion. Effusions were categorized as exudates or transudates according to the Light criteria [23] . Empyema or complicated parapneumonic effusion was established by one or more of the following criteria: purulent fluid on macroscopic examination, positive Gram stain and/or micro-organism growth in culture and pH < 7.2 or glucose < 40 mg/dl in association with pneumonia [4] . Tuberculous pleurisy was defined by positive Ziehl-Nielssen stain or Löwenstein-Jensen culture of pleural fluid or pleural biopsy specimens, or by adenosine deaminase concentrations in pleural fluid > 43 international units/l plus lymphocytes > 50 % of the total cell count, positive purified protein derivative skin test (PPD+), a clinical course suggestive of tuberculosis and good response to antituberculosis treatment [24] . Effusions were considered malignant on evidence of malignancy at cytological study or pleural biopsy.
Biochemical analysis
For TNF-α, IL-8 and polymorphonuclear elastase measurement, samples were collected in tubes containing EDTA (Becton Dickinson, Plymouth, Devon, U.K.) and centrifuged at 1050 g for 15 min. The supernatant was kept in aliquots at − 70
• C until analysis. TNF-α and IL-8 were measured by ELISA (Innogenetics, Zwijndrecht, Belgium and Bender Medsystems, Vienna, Austria for TNF-α and IL-8 respectively). Polymorphonuclear elastase was assessed with an immunoagglutination method (ECOLINE-polymorphonuclear elastase; Merck, Darmstadt, Germany). In our laboratory, the detection limit of the method for TNF-α and IL-8 was 6 ng/l and 8 ng/l respectively. Concentrations below the detection limit were set to 1 ng/l for statistical purposes.
For analysis of fibrinolytic system variables, samples were collected in vacutainer tubes on 3.8 % citrate (Becton Dickinson). Pleural samples were centrifuged at 1150 g for 30 min, and the supernatant was frozen at − 70
• C until analysis within the subsequent 6 months. Plasminogen was evaluated using a chromogenic substrate (Behringwerke, Marburg, Germany). t-PA, u-PA, PAI 1 and PAI 2 concentrations were determined by ELISA (Tintelize Biopool, Umea, Sweden). PAI 1 activity was determined by a functional assay using a chromogenic substrate (Chromogenix, Stockholm, Sweden). The detection limits of the methods for u-PA and PAI 2 concentrations and for PAI 1 activity in our laboratory were 0.1 ng/ml, 6 ng/ml and 5 units/ml respectively. Concentrations of u-PA and PAI 2 and PAI 1 activity below the detection limit were set to 0.1 for statistical purposes.
Statistical analysis
The Wilcoxon signed-rank test was used to assess the difference between plasma and pleural levels of fibrinolytic parameters. The Wilcoxon rank sum test was used to compare the pleural fluid level of fibrinolytic and inflammatory markers between infectious and non-infectious effusions, and between empyema or complicated parapneumonic and tuberculous effusions. PAI 1 and PAI 2 concentrations and PAI 1 activity, as well as plasminogen, u-PA, t-PA, D-dimer, IL-8, TNF-α and polymorphonuclear elastase levels, were submitted to logarithmic transformation for the following analysis. The Pearson correlation coefficient was then estimated to assess the relationships between the fibrinolytic variables and pleural fluid inflammatory markers. Statistical analyses were performed with SPSS software (SPSS for Windows, Release 6.0; SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Inflammatory mediators
Pleural fluid inflammatory mediator levels are summarized according to the aetiology of pleural effusion in Table 1 . Levels of all the inflammatory mediators were higher in empyema and complicated parapneumonic effusions than in malignant effusions (P < 0.001). IL-8 and polymorphonuclear elastase concentrations were higher in empyema and complicated parapneumonic compared with tuberculous effusions (P < 0.001). 
Fibrinolytic system
Comparisons between plasma and pleural fluid fibrinolytic system levels according to the aetiology of pleural effusions are shown in Table 2 . Exudates showed significantly higher concentrations of fibrinolytic markers in pleural fluid than in plasma. In transudates, differences between blood and pleural fluid fibrinolytic markers were absent or weak. Plasminogen and PAI levels were statistically higher in empyema, complicated parapneumonic and tuberculous effusions compared with malignant effusions (P < 0.001). PAI 2 was the only parameter showing higher concentrations in empyema and complicated parapneumonic effusions compared with tuberculous effusions (P < 0.001; results not shown). The correlation between PAI 1 concentration and activity was 0.810 (P < 0.001).
t-PA levels were lower in empyema and complicated parapneumonic compared with tuberculous (P = 0.02) or malignant effusions (P < 0.001). There were no significant differences in pleural u-PA values according to the aetiology of the pleural effusion. Table 3 summarizes the correlation between inflammatory mediators and fibrinolytic system parameters in exudative effusions. TNF-α, IL-8 and polymorphonuclear elastase were significantly associated with PAIs in the total of exudative pleural effusions, but significance was lost when empyema and complicated parapneumonic effusions were analysed separately.
Associations between inflammatory and fibrinolysis parameters
The negative correlation found between t-PA and both IL-8 and polymorphonuclear elastase in exudative effusion was maintained in empyema, complicated parapneumonic effusions and tuberculous effusions (r = −0.4963; P = 0.01). No significant correlation between the fibrinolytic system and inflammatory markers was found in malignant and transudative pleural effusions.
DISCUSSION
The pleural inflammatory response is mediated by the early release of potent proinflammatory cytokines by mesothelial cells [25] . IL-8 and TNF-α are two important cytokines involved in acute pleural inflammation leading to the development of parapneumonic effusion [4] [5] [6] [7] [8] [9] [10] . Consistent with previous reports [4, 5, 9, 11] , IL-8 and polymorphonuclear elastase fluid levels in our patients were increased in infectious effusions, particularly empyema and complicated parapneumonic effusions, whereas tuberculous pleural fluid showed the highest TNF-α level [10] .
Complications in infectious pleural effusions are characterized by local fibrin deposition in the pleural space [19] . Experimental studies have shown that mesothelial and inflammatory cells can excrete fibrinolytic [17] . In the present study, pleural fluid levels of PAIs were 10-300 times higher in exudates than in transudates, suggesting local activation of the fibrinolysis system in exudative pleural effusions. Furthermore, pleural fluid concentrations of fibrinolytic markers were higher than plasma concentrations in exudates, whereas, in transudates, these differences were either absent or weak. An imbalance between fibrinolytic system activation/ inhibition in the pleural space could account for the abnormal fibrin turnover seen in some pleural effusions [20, 26] . Among previous reports studying regulation and deposition of fibrin in the pleural space [21, [26] [27] [28] [29] , it has been demonstrated that infectious effusions have the highest levels of PAIs, whereas malignant effusions are characterized by enhanced fibrinolytic activity with high levels of both PAs. These studies have also shown that the local inflammation produced by effective pleurodesis provokes an increase in PAI activity and a decrease in fibrinolytic activity, mediated by a decrease in Ddimer values. Patients with poor response to pleurodesis show increased fibrinolysis and elevated D-dimer values [21, 27, 30] . Results from another study [26] , however, showed no differences in PAs between malignant and benign pleural effusions.
In our present study, PAI levels were increased in both types of infectious effusions. Although complicated parapneumonic and tuberculous effusions did not show differences in PAI 1 concentration or activity, PAI 2 concentration was significantly increased in empyema and complicated parapneumonic effusions, a fact that could contribute, at least partially, to the higher pleural fibrin deposition seen in this type of effusion.
We found disparate results for fibrinolytic activity as expressed by t-PA and u-PA values. t-PA was decreased in infectious and increased in malignant effusions, whereas there were no differences in u-PA values between benign and malignant exudates. Empyema and complicated parapneumonic pleural effusion showed the lowest t-PA values, tuberculous effusion had an intermediate level and malignant fluid showed the highest values. It is possible that the development of clinical complications in empyema and complicated parapneumonic effusions could be related to this low fibrinolytic activity. It may also be that the high pleural u-PA seen in infectious effusions is mainly due to the PAI 1-linked fraction, which does not have fibrinolytic activity.
The association between cytokines and the fibrinolytic system in pleural effusions is poorly understood, although several studies on this subject have been performed in sepsis [12] [13] [14] [15] . To our knowledge, only two studies in pleural effusions associate TNF-α and the fibrinolytic system. In an experimental study, mesothelial cells were reported to induce the release of PAIs after TNF-α injection in 22 human pleural cell cultures [17] . A clinical study showed that higher TNF-α and PAI 1 concentrations were associated with pachypleuritis in patients with tuberculous pleurisy [18] . IL-8 has been considered an important chemoattractant for polymorphonuclear leucocytes that activates the release of polymorphonuclear elastase [4] . Sepsis studies have demonstrated that this cytokine contributes to activation of PAI 1 and blockage of fibrinolytic activity [15] . Some experimental studies have shown that polymorphonuclear elastase blocks plasminogen conversion into plasmin by acting upon t-PA, thereby inhibiting fibrinolysis, but, on the other hand, polymorphonuclear elastase inactivates PAI 1, enhancing fibrinolysis [31] [32] [33] [34] . Thus the role of the inflammatory mediators in pleural fluid is still to be established.
In the present study, TNF-α, IL-8 and polymorphonuclear elastase correlated with PAI levels in the overall group of exudative effusions, but not specifically in empyema or complicated parapneumonic effusions. IL-8 and polymorphonuclear elastase showed a high negative correlation with t-PA in all exudates, and this significant association persisted in tuberculous effusions and, particularly, in empyema and complicated parapneumonic effusions.
Blockage of fibrin breakdown and its consequent deposition in the pleural space in empyema and complicated parapneumonic effusions is associated with high levels of PAIs and decreased t-PA. Therefore blockage of the fibrinolytic activity by IL-8 and polymorphonuclear elastase would favour the development of loculations in empyema and complicated parapneumonic pleural effusions.
In conclusion, pleural fibrin deposition in empyema and complicated parapneumonic effusions appears to be a consequence, at least in part, of a blockade of fibrin clearance associated with the release of neutrophil activation mediators.
